93 related articles for article (PubMed ID: 8293527)
1. Amino acids and peptides. XXXVI. Synthesis of enkephalin chloromethyl ketone and evaluation of its inhibitory activity against endopeptidase 22.19.
Taguchi H; Nishiyama Y; Camargo AC; Okada Y
Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):2038-9. PubMed ID: 8293527
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
Odake S; Kam CM; Powers JC
J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 3H-Tyr-D-Ala-Gly-N(Me)Phe chloromethyl ketone--an opioid affinity label.
Varga E; Tóth G; Hepp J; Benyhe S; Simon J; Medzihradszky K; Borsodi A
Neuropeptides; 1988 Oct; 12(3):135-9. PubMed ID: 2853836
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of tripeptide chloromethyl ketones and examination of their inhibitory effects on plasmin and plasma kallikrein.
Tsuda Y; Teno N; Okada Y; Wanaka K; Bohgaki M; Hijikata-Okunomiya A; Okamoto U; Naito T; Okamoto S
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3108-11. PubMed ID: 2534361
[TBL] [Abstract][Full Text] [Related]
5. Design of opioid peptides for a potential delta-receptor affinity label function: comparison with the mu-specific Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone.
Rónai AZ; Hepp J; Magyar A; Borsodi A; Medzihradszky K
Pharmacology; 1994 Aug; 49(2):121-31. PubMed ID: 7972321
[TBL] [Abstract][Full Text] [Related]
6. A potent peptide affinity reagent for the opiate receptor.
Venn RF; Barnard EA
J Biol Chem; 1981 Feb; 256(4):1529-32. PubMed ID: 6257675
[TBL] [Abstract][Full Text] [Related]
7. Identification of an opioid receptor subunit carrying the mu binding site.
Newman EL; Barnard EA
Biochemistry; 1984 Nov; 23(23):5385-9. PubMed ID: 6095896
[TBL] [Abstract][Full Text] [Related]
8. Opioid receptor labeling with the chloromethyl ketone derivative of [3H]Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) II: Covalent labeling of mu opioid binding site by 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl ketone.
Oktem HA; Moitra J; Benyhe S; Toth G; Lajtha A; Borsodi A
Life Sci; 1991; 48(18):1763-8. PubMed ID: 1850495
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of subtilisin BPN' with peptide chloromethyl ketones.
Powers JC; Lively MO; Tippett JT
Biochim Biophys Acta; 1977 Jan; 480(1):246-61. PubMed ID: 831835
[TBL] [Abstract][Full Text] [Related]
10. Amino acids and peptides. XXIV. Preparation and antinociceptive effect of [D-Ala2,(N-Me)Phe4]enkephalin analog-poly(ethylene glycol) hybrids.
Maeda M; Kawasaki K; Takahashi M; Nakao K; Kaneto H
Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1859-63. PubMed ID: 7954939
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of calpain I and calpain II by specificity-oriented tripeptidyl chloromethyl ketones.
Sasaki T; Kikuchi T; Fukui I; Murachi T
J Biochem; 1986 Jan; 99(1):173-9. PubMed ID: 3007444
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of chloromethyl ketones of leucine enkephalin.
Pelton JT; Johnston RB; Balk JL; Schmidt CJ; Roche EB
Biochem Biophys Res Commun; 1980 Dec; 97(4):1391-8. PubMed ID: 7213365
[No Abstract] [Full Text] [Related]
13. Synthesis and application of MeOSuc-Ala-Ala-Pro-Phe-CH2Cl as potent proteinase K inhibitor.
Kore AR; Shanmugasundaram M; Hoang Q; Kuo M; Chapman LM; Chen HH
Bioorg Med Chem Lett; 2009 Mar; 19(5):1296-300. PubMed ID: 19211247
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor labeling with the chloromethyl ketone derivative of (3)H-Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) I: Binding properties of 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl.
Oktem HA; Varga E; Hepp J; Medzihradzky K; Lajtha A; Borsodi A
Life Sci; 1991; 48(18):1757-62. PubMed ID: 1850494
[TBL] [Abstract][Full Text] [Related]
15. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
16. Effects of thioamide substitution for the enkephalin conformation. Crystal structure of Boc-Tyr-Gly-Gly-Phe psi [CSNH]Leu-OBzl.
Doi M; Takehara S; Ishida T; Inoue M
Int J Pept Protein Res; 1989 Nov; 34(5):369-73. PubMed ID: 2613438
[TBL] [Abstract][Full Text] [Related]
17. Delta opioid receptor selectivity induced by conformational constraints in linear enkephalin-related peptides: 1H 400-MHz NMR study and theoretical calculations.
Belleney J; Gacel G; Fournié-Zaluski MC; Maigret B; Roques BP
Biochemistry; 1989 Sep; 28(18):7392-400. PubMed ID: 2554969
[TBL] [Abstract][Full Text] [Related]
18. Effects of a series of chloromethyl ketone protease inhibitors on superoxide release and the glutathione system in human polymorphonuclear leukocytes and alveolar macrophages.
Sibille Y; Merrill WW; Cooper JA; Polomski L; Gee JB
Am Rev Respir Dis; 1984 Jul; 130(1):110-4. PubMed ID: 6331236
[TBL] [Abstract][Full Text] [Related]
19. Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences.
Bojnik E; Magyar A; Tóth G; Bajusz S; Borsodi A; Benyhe S
Neuroscience; 2009 Jan; 158(2):867-74. PubMed ID: 18977279
[TBL] [Abstract][Full Text] [Related]
20. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
Bock PE
Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
